Stanford's 37 thousand SI agents work through 50 thousand clinical trials in a week and come up with a lung cancer drug themselves
Prepared by Sintelligent with the help of SI. Publication time restored from the build log. . Updated: .
A whole "company" of SI agents does in a week work that would take people years, and guesses drugs before pharma giants: medicine is speeding up many times over.
In a paper in Science, James Zou's group created a "virtual biotech company" of 37 thousand agents covering the entire drug development pipeline. In a week they analyzed about 50 thousand trials and found a pattern: drugs hitting genes with "switch-like" activity in specific cell types are 40% more likely to move from phase one to phase two, 48% more likely to reach the market and have 32% fewer side effects. The agents also proposed an antibody-drug conjugate against B7-H3 for lung cancer; later a major pharmaceutical company independently went the same way and received breakthrough therapy designation from the FDA.
Sources 2